EGFR and hepatocellular carcinoma: A study about HCC shows that the lnc-epidermal growth factor receptor (lnc-EGFR) encourages the development of Treg cells and prevents the activity of cytotoxic T lymphocytes (CTLs) (Jiang et al., 2017).